Search Results

Mawi DNA Technologies announced that it has signed Memorandum of Understanding agreements with the Moroccan Ministry of Investment, Convergence and Evaluation of Public Policies as well as with the Moroccan Ministry of Industry and Commerce to explore a joint venture with Mawi’s local partner BIOTESSIA to establish a state-of-the-art manufacturing facility in Morocco to serve the African market.

Mawi DNA Technologies announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s iSWAB-Respiratory Tract Sample Collection Media-Extraction Less™ (iSWAB-RC-EL).

Mawi DNA Technologies (Mawi), a medical device company focusing on the development of innovative technologies for biosampling, has launched the NextSWAB™, a 100% medical-grade plastic swab designed and manufactured in the US.

Mawi DNA Technologies has signed a distribution agreement with FUJIFILM Wako Pure Chemical Corporation, a leader in the biomedical industry, to deliver Mawi’s iSWAB biosampling technologies to Japan.

Mawi DNA Technologies, a leading biosampling collection company, announces it has been awarded the ISO 9001:2015 Quality Management Systems and ISO 13485:2016 Medical Devices Quality Management Systems certifications.

Mawi DNA Technologies, a leader in biosample collection technologies, announces the company received CE Mark and UK MHRA approval for its portfolio of iSWAB non-invasive collection devices.

DNA Nanobots, a biotechnology leader in DNA nanoparticles engineered for targeted therapeutics, announced that it completed exclusive commercial licensing of a gene editing technology from the University of California Berkeley.